ARVEE LABORATORIES (INDIA)
|
ARVEE LABORATORIES (INDIA) Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 2.29 | 1.95 | 0.95 | 3.74 | 2.34 |
| CEPS(Rs) | 3.39 | 2.99 | 2.31 | 5.63 | 4.44 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 30.66 | 28.37 | 26.42 | 25.46 | 21.72 |
| Tax Rate(%) | -3.95 | 25.20 | 42.51 | 33.19 | 25.38 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 10.12 | 9.38 | 9.68 | 11.87 | 13.95 |
| EBIT Margin(%) | 8.46 | 8.10 | 6.85 | 10.68 | 9.47 |
| Pre Tax Margin(%) | 7.71 | 7.46 | 6.03 | 10.05 | 8.55 |
| PAT Margin (%) | 8.02 | 5.58 | 3.47 | 6.71 | 6.38 |
| Cash Profit Margin (%) | 11.87 | 8.56 | 8.40 | 10.10 | 12.14 |
| Performance Ratios | |||||
| ROA(%) | 6.28 | 5.64 | 2.72 | 10.65 | 6.46 |
| ROE(%) | 7.77 | 7.11 | 3.68 | 15.84 | 11.36 |
| ROCE(%) | 7.93 | 10.00 | 7.03 | 23.35 | 13.33 |
| Asset Turnover(x) | 0.78 | 1.01 | 0.79 | 1.59 | 1.01 |
| Sales/Fixed Asset(x) | 0.85 | 1.13 | 0.97 | 2.03 | 1.41 |
| Working Capital/Sales(x) | 1.77 | 2.43 | 3.08 | 4.82 | 3.97 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.18 | 0.88 | 1.04 | 0.49 | 0.71 |
| Receivable days | 109.16 | 68.81 | 110.50 | 72.55 | 90.55 |
| Inventory Days | 79.60 | 51.92 | 65.94 | 30.63 | 59.55 |
| Payable days | 120.35 | 87.33 | 180.60 | 82.15 | 157.69 |
| Valuation Parameters | |||||
| PER(x) | 58.39 | 72.87 | 150.24 | 23.54 | 48.68 |
| PCE(x) | 39.44 | 47.47 | 61.97 | 15.64 | 25.60 |
| Price/Book(x) | 4.37 | 5.01 | 5.43 | 3.46 | 5.23 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 4.67 | 3.96 | 5.18 | 1.58 | 3.07 |
| EV/Core EBITDA(x) | 37.91 | 35.75 | 43.93 | 11.25 | 20.16 |
| EV/EBIT(x) | 55.18 | 48.92 | 75.60 | 14.81 | 32.41 |
| EV/CE(x) | 4.21 | 4.73 | 5.22 | 3.34 | 3.20 |
| M Cap / Sales | 4.68 | 4.07 | 5.21 | 1.58 | 3.11 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -18.12 | 26.83 | -50.54 | 52.12 | -14.88 |
| Core EBITDA Growth(%) | -9.12 | 19.31 | -58.57 | 40.61 | -7.32 |
| EBIT Growth(%) | -14.55 | 50.03 | -68.28 | 71.58 | -9.45 |
| PAT Growth(%) | 17.65 | 104.15 | -74.46 | 60.04 | -3.87 |
| EPS Growth(%) | 17.65 | 104.15 | -74.46 | 60.03 | -3.86 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.03 | 0.03 | 0.03 | 0.04 | 0.13 |
| Current Ratio(x) | 3.55 | 5.14 | 2.38 | 2.44 | 1.75 |
| Quick Ratio(x) | 2.23 | 3.95 | 1.49 | 1.92 | 1.33 |
| Interest Cover(x) | 11.35 | 12.56 | 8.33 | 16.89 | 10.31 |
| Total Debt/Mcap(x) | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
Compare Financial Ratios of peers of ARVEE LABORATORIES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ARVEE LABORATORIES (INDIA) | ₹244.2 Cr | -5.6% | 2.7% | 40.7% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹173,654.0 Cr | 3.1% | -4.5% | 43.4% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹155,632.0 Cr | -3.6% | 1.5% | 8.2% | Stock Analytics | |
| SRF | ₹73,365.1 Cr | 0.1% | -0.8% | -14.4% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹51,767.9 Cr | 2.8% | 1.8% | 34.6% | Stock Analytics | |
| GODREJ INDUSTRIES | ₹37,823.3 Cr | 15.7% | 11.8% | 2.6% | Stock Analytics | |
ARVEE LABORATORIES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ARVEE LABORATORIES (INDIA) | -5.6% |
2.7% |
40.7% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses